BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rostami N, Keshtkar-Jahromi M, Rahnavardi M, Keshtkar-Jahromi M, Esfahani FS. Effect of eradication of Helicobacter pylori on platelet recovery in patients with chronic idiopathic thrombocytopenic purpura: a controlled trial. Am J Hematol 2008;83:376-81. [PMID: 18183613 DOI: 10.1002/ajh.21125] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Fan D, Gong Y, Sun L, Zhang Y, Zhang J. Comparative transcriptome analysis to investigate the mechanism of anti-Helicobacter pylori activity of zinc. Microb Pathog 2022;168:105611. [PMID: 35660509 DOI: 10.1016/j.micpath.2022.105611] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Bangolo A, Ahmed M, Atoot A, Mahmoud A, Agbakwuru-Onyike C, Palad MKLY, Sciarra M, Atoot A. An Unusual Cause of Secondary ITP in a 34-Year-Old Hispanic Male. Case Rep Hematol 2021;2021:7965930. [PMID: 34976420 DOI: 10.1155/2021/7965930] [Reference Citation Analysis]
3 Weng CY, Xu JL, Sun SP, Wang KJ, Lv B. Helicobacter pylori eradication: Exploring its impacts on the gastric mucosa. World J Gastroenterol 2021; 27(31): 5152-5170 [PMID: 34497441 DOI: 10.3748/wjg.v27.i31.5152] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pezeshki SMS, Saki N, Ghandali MV, Ekrami A, Avarvand AY. Effect of Helicobacter Pylori eradication on patients with ITP: a meta-analysis of studies conducted in the Middle East. Blood Res 2021;56:38-43. [PMID: 33707351 DOI: 10.5045/br.2021.2020189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
5 Belizaire R, Makar RS. Non-Alloimmune Mechanisms of Thrombocytopenia and Refractoriness to Platelet Transfusion. Transfus Med Rev 2020;34:242-9. [PMID: 33129606 DOI: 10.1016/j.tmrv.2020.09.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
6 Guevara B, Cogdill AG. Helicobacter pylori: A Review of Current Diagnostic and Management Strategies. Dig Dis Sci 2020;65:1917-31. [PMID: 32170476 DOI: 10.1007/s10620-020-06193-7] [Cited by in Crossref: 44] [Cited by in F6Publishing: 43] [Article Influence: 14.7] [Reference Citation Analysis]
7 Choi DS, Seo SI, Shin WG, Park CH. Risk for Colorectal Neoplasia in Patients With Helicobacter pylori Infection: A Systematic Review and Meta-analysis. Clin Transl Gastroenterol 2020;11:e00127. [PMID: 32032128 DOI: 10.14309/ctg.0000000000000127] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
8 Kim BJ, Kim HS, Jang HJ, Kim JH. Helicobacter pylori Eradication in Idiopathic Thrombocytopenic Purpura: A Meta-Analysis of Randomized Trials. Gastroenterol Res Pract. 2018;2018:6090878. [PMID: 30402091 DOI: 10.1155/2018/6090878] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
9 Hwang JJ, Lee DH, Yoon H, Shin CM, Park YS, Kim N. The Effects of Helicobacter pylori Eradication Therapy for Chronic IdiopathicThrombocytopenic Purpura. Gut Liver 2016;10:356-61. [PMID: 26347517 DOI: 10.5009/gnl14483] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
10 Sheema K, Ikramdin U, Arshi N, Farah N, Imran S. Role of Helicobacter pylori Eradication Therapy on Platelet Recovery in Chronic Immune Thrombocytopenic Purpura. Gastroenterol Res Pract 2017;2017:9529752. [PMID: 28194178 DOI: 10.1155/2017/9529752] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]
11 Mavis O, Kapucu K. Relationship between the Level of <i>Helicobacter pylori</i> and Number of Platelets in Non-ITP Patients Who Underwent Gastroscopy. OJGas 2017;07:165-172. [DOI: 10.4236/ojgas.2017.75018] [Reference Citation Analysis]
12 Xiong LJ, Mao M. Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children. World J Clin Pediatr 2016; 5(1): 82-88 [PMID: 26862506 DOI: 10.5409/wjcp.v5.i1.82] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
13 Zhang XH, He Y, Feng R, Xu LP, Jiang Q, Jiang H, Lu J, Fu HX, Liu H, Wang JW, Wang QM, Feng FE, Zhu XL, Xu LL, Xie YD, Ma H, Wang H, Liu KY, Huang XJ. Helicobacter pylori infection influences the severity of thrombocytopenia and its treatment response in chronic hepatitis B patients with compensatory cirrhosis: A multicenter, observational study. Platelets 2016;27:223-9. [PMID: 26338255 DOI: 10.3109/09537104.2015.1077946] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
14 Frydman GH, Davis N, Beck PL, Fox JG. Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography. Helicobacter 2015;20:239-51. [PMID: 25728540 DOI: 10.1111/hel.12200] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 4.9] [Reference Citation Analysis]
15 Perricone C, Rinaldi M, Perricone R, Shoenfeld Y. Immune Thrombocytopenic Purpura: Between Infections and Vaccinations. Vaccines and Autoimmunity 2015. [DOI: 10.1002/9781118663721.ch28] [Reference Citation Analysis]
16 Cover TL, Blaser MJ. Helicobacter pylori and Other Gastric Helicobacter Species. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2015. [DOI: 10.1016/b978-1-4557-4801-3.00219-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
17 Rinaldi M, Perricone C, Ortega-Hernandez OD, Perricone R, Shoenfeld Y. Immune thrombocytopaenic purpura: an autoimmune cross-link between infections and vaccines. Lupus 2014;23:554-67. [PMID: 24763539 DOI: 10.1177/0961203313499959] [Cited by in Crossref: 44] [Cited by in F6Publishing: 48] [Article Influence: 4.9] [Reference Citation Analysis]
18 Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol 2014; 20(36): 12818-12838 [PMID: 25278680 DOI: 10.3748/wjg.v20.i36.12818] [Cited by in CrossRef: 43] [Cited by in F6Publishing: 44] [Article Influence: 4.8] [Reference Citation Analysis]
19 Rocha AM, Souza C, Melo FF, Clementino NC, Marino MC, Rocha GA, Queiroz DM. Cytokine profile of patients with chronic immune thrombocytopenia affects platelet count recovery after Helicobacter pylori eradication. Br J Haematol. 2015;168:421-428. [PMID: 25257094 DOI: 10.1111/bjh.13141] [Cited by in Crossref: 15] [Cited by in F6Publishing: 19] [Article Influence: 1.7] [Reference Citation Analysis]
20 Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, Miwa H, Lim KJ, Das KM. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol 2014; 20(18): 5461-5473 [PMID: 24833876 DOI: 10.3748/wjg.v20.i18.5461] [Cited by in CrossRef: 145] [Cited by in F6Publishing: 154] [Article Influence: 16.1] [Reference Citation Analysis]
21 Robinson K, Atherton JC. Helicobacter pylori. In: Fratamico PM, Smith JL, Brogden KA, editors. Sequelae and Long-Term Consequences of Infectious Diseases. Washington: ASM Press; 2009. pp. 107-33. [DOI: 10.1128/9781555815486.ch7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
22 Teawtrakul N, Sawadpanich K, Sirijerachai C, Chansung K, Wanitpongpun C. Clinical characteristics and treatment outcomes in patients with Helicobacter pylori-positive chronic immune thrombocytopenic purpura. Platelets. 2014;25:548-551. [PMID: 24176049 DOI: 10.3109/09537104.2013.841883] [Cited by in Crossref: 3] [Cited by in F6Publishing: 6] [Article Influence: 0.3] [Reference Citation Analysis]
23 Mawanda F, Wallace R. Can infections cause Alzheimer's disease? Epidemiol Rev 2013;35:161-80. [PMID: 23349428 DOI: 10.1093/epirev/mxs007] [Cited by in Crossref: 74] [Cited by in F6Publishing: 75] [Article Influence: 7.4] [Reference Citation Analysis]
24 Cox D, Kerrigan SW, Watson SP. Platelets and the innate immune system: mechanisms of bacterial-induced platelet activation. J Thromb Haemost 2011;9:1097-107. [PMID: 21435167 DOI: 10.1111/j.1538-7836.2011.04264.x] [Cited by in Crossref: 198] [Cited by in F6Publishing: 207] [Article Influence: 16.5] [Reference Citation Analysis]
25 Wang AY, Peura DA. The prevalence and incidence of Helicobacter pylori-associated peptic ulcer disease and upper gastrointestinal bleeding throughout the world. Gastrointest Endosc Clin N Am 2011;21:613-35. [PMID: 21944414 DOI: 10.1016/j.giec.2011.07.011] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
26 Sato R, Murakami K, Okimoto T, Watanabe K, Kodama M, Fujioka T. Development of corpus atrophic gastritis may be associated with Helicobacter pylori-related idiopathic thrombocytopenic purpura. J Gastroenterol 2011;46:991-7. [PMID: 21594563 DOI: 10.1007/s00535-011-0416-8] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 1.3] [Reference Citation Analysis]
27 Russo G, Miraglia V, Branciforte F, Matarese SM, Zecca M, Bisogno G, Parodi E, Amendola G, Giordano P, Jankovic M. Effect of eradication of Helicobacter pylori in children with chronic immune thrombocytopenia: a prospective, controlled, multicenter study. Pediatr Blood Cancer. 2011;56:273-278. [PMID: 20830773 DOI: 10.1002/pbc.22770] [Cited by in Crossref: 44] [Cited by in F6Publishing: 49] [Article Influence: 3.4] [Reference Citation Analysis]
28 Kanapuru B, Ershler WB. Blood Disorders in the Elderly. Brocklehurst's Textbook of Geriatric Medicine and Gerontology 2010. [DOI: 10.1016/b978-1-4160-6231-8.10093-5] [Reference Citation Analysis]
29 Peura DA, Crowe SE. Helicobacter pylori. Sleisenger and Fordtran's Gastrointestinal and Liver Disease 2010. [DOI: 10.1016/b978-1-4160-6189-2.00050-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
30 Veres G, Karóczkai I, Bodánszky H, Marosi A, Magyarossi E, Dezsofi A, Arató A. [The role of Helicobacter pylori infection in children with chronic immune thrombocytopenic purpura]. Orv Hetil. 2009;150:801-804. [PMID: 19362936 DOI: 10.1556/oh.2009.28581] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
31 Treepongkaruna S, Sirachainan N, Kanjanapongkul S, Winaichatsak A, Sirithorn S, Sumritsopak R, Chuansumrit A. Absence of platelet recovery following Helicobacter pylori eradication in childhood chronic idiopathic thrombocytopenic purpura: a multi-center randomized controlled trial. Pediatr Blood Cancer. 2009;53:72-77. [PMID: 19301380 DOI: 10.1002/pbc.21991] [Cited by in Crossref: 30] [Cited by in F6Publishing: 36] [Article Influence: 2.1] [Reference Citation Analysis]
32 Moyaert H, Franceschi F, Roccarina D, Ducatelle R, Haesebrouck F, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection: other Helicobacters. Helicobacter 2008;13 Suppl 1:47-57. [PMID: 18783522 DOI: 10.1111/j.1523-5378.2008.00634.x] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 1.5] [Reference Citation Analysis]